An Exploratory Study of Cognitive Function and Central Adiposity in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

To prospectively assess cognitive function, anthropomorphic measures, and bone mineral density in men receiving androgen deprivation therapy (ADT) for prostate cancer; explore relationships between cognitive function and central adiposity; and gather preliminary data from a personalized education, e...

Full description

Saved in:
Bibliographic Details
Published inOncology nursing forum Vol. 49; no. 2; pp. 142 - 150
Main Authors Myers, Jamie S, Manson, Alana, Billinger, Sandra A, Parker, William, Hamilton-Reeves, Jill, Diaz, Francisco J, Krebill, Ron, Maliski, Sally
Format Journal Article
LanguageEnglish
Published United States Oncology Nursing Society 01.03.2022
Subjects
Adiposity
Androgen Antagonists - adverse effects
Androgen suppression therapy
Androgens
Body mass index
Bone Density
Cognition
Cognition & reasoning
Cognition disorders
Complications and side effects
Drug therapy
Exercise
Humans
Male
Nursing care
Nutrition
Oncology
Osteoporosis
Prospective Studies
Prostate cancer
Prostatic Neoplasms - psychology
Risk factors
Weight gain
United States
cognitive function
prostate cancer
central adiposity
androgen deprivation
Online AccessGet full text

Cover

More Information
Summary:To prospectively assess cognitive function, anthropomorphic measures, and bone mineral density in men receiving androgen deprivation therapy (ADT) for prostate cancer; explore relationships between cognitive function and central adiposity; and gather preliminary data from a personalized education, exercise, and nutrition intervention. 33 participants consented from a randomized controlled intervention trial. Neurocognitive performance and self-report of cognitive function were assessed at baseline and 6 and 12 months. Dual-energy x-ray absorptiometry (DEXA) scans were obtained at baseline and 6 months. No between-group differences in cognitive function were demonstrated. Increased visceral adiposity was not associated with decrements in visuospatial abilities. Significant increases in fat mass without increases in body mass index or waist-hip ratio provided further evidence for DEXA as the preferred central adiposity measure. Well-powered prospective research is needed to fully characterize the effects of ADT on cognitive function and the potential benefits of exercise and nutrition-based interventions.
ISSN:0190-535X
1538-0688
DOI:10.1188/22.ONF.142-150